A Case Study Associated with Oropharyngeal Cancer

References

1. 1. Ko C,
   2. Citrin D

   . Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck. Oral Dis. 2009;15(2):121-132.

   OpenUrlPubMed
2. 1. Sciubba JJ

   . Post-treatment issues in the head and neck cancer patient. Support for People with Oral and Head and Neck Cancer. 2009;19(3):1-3.

   OpenUrl
3. 1. Haddad RI,
   2. Shin DM

   . Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143-1154.

   OpenUrlCrossRefPubMedWeb of Science
4. 1. Eichmiller FC,
   2. Eidelman N,
   3. Carey CM

   . Controlling fluoride dosage in a patient with compromised salivary function. J Am Dent Assoc. 2005;136(1):67-70.

   OpenUrlAbstract/FREE Full Text
5. 1. Chambers MS,
   2. Mellberg JR,
   3. Keene HJ,
   4. et al

   . Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides. Oral Oncology. 2006;42:934-945.

   OpenUrlPubMed
6. 1. Harris NO,
   2. Garcia-Godoy F,
   3. Nathe CN

   1. Maurizio SJ

   . Oral cancer. In: Harris NO, Garcia-Godoy F, Nathe CN, eds. Primary preventive dentistry. 7th ed. Upper Saddle River (NJ): Pearson; 2009:67-98.
7. 1. GCAmerica

   . MI Paste™ protocol. [cited 2009 Feb 4]. Available from: http://www.gcamerica.com/images/pdfs/MIPasteProtocols10806rev6.pdf.
8. 1. Ranjitkar S,
   2. Rodriguez JM,
   3. Kaidonis JA,
   4. Richards LC,
   5. Townsend GC,
   6. Bartlett DW

   . The effect of casein phosphopeptide-amorphous calcium phosphate on erosive enamel and dentine wear by toothbrush abrasion. J Dent. 2009;37(4):250-254.

   OpenUrlPubMed
9. 1. Reynolds EC

   . Casein phosphopeptide-amorphous calcium phosphate: The scientific evidence. Adv Dent Res. 2009;21(1):25-29.

   OpenUrlFREE Full Text
10. 1. McClure D,
    2. Essary D,
    3. Gurenlian JR

    . A collaborative team approach for symptom management for head and neck cancer patients. Grand Rounds in Oral-Systemic Medicine. 2007;2(1):43-53.

    OpenUrl
11. 1. Regezi JA,
    2. Sciubba JJ,
    3. Jordan RCK

    . Oral pathology: Clinical pathologic correlations. 5th ed. St. Louis, (MO): Saunders Elsevier; 2008:48-69.
12. 1. Shah JP,
    2. Gil Z

    . Current concepts in management of oral cancer—surgery. Oral Oncol. 2009;45(4-5):394-401.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Pagedar NA,
    2. Gilbert RW

    . Selective neck dissection: A review of the evidence. Oral Oncol. 2009;45(4-5):416-420.

    OpenUrlPubMed
14. Stage Information for Oropharyngeal Cancer. National Cancer Institute [Internet]. 2009 [cited 2009 Feb 4]. Available from: www.cancer.gov/cancertopics/pdq/treatment/oropharyngeal/HealthProfessional/page4.
15. 1. van der Schroeff MP,
    2. Baatenburg de Jong RJ

    . Staging and prognosis in head and neck cancer. Oral Oncol. 2009;45(4-5):356-360.

    OpenUrlCrossRefPubMed
16. 1. Kademani D

    . Oral cancer. Mayo Clin Proc. 2007;82(7):878-887.

    OpenUrlCrossRefPubMedWeb of Science
17. 1. Grégoire V,
    2. De Neve W,
    3. Eisbruch A,
    4. Lee N,
    5. Van den Weyngaert D,
    6. Van Gestel D

    . Intensity-Modulated Radiation Therapy for head and neck carcinoma. Oncologist. 2007;12(5):555-564.

    OpenUrlAbstract/FREE Full Text
18. 1. Bhide SA,
    2. Miah AB,
    3. Harrington KJ,
    4. Newbold KL,
    5. Nutting CM

    . Radiation-induced xerostomia: Pathophysiology, prevention and treatment. Clin Oncol (R Coll Radiol). 2009;21(10):737-744.

    OpenUrlPubMed
19. 1. Tepper J,
    2. Krasna MJ,
    3. Niedzwiecki D,
    4. et al

    . Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB9781. J Clin Oncol. 2008;26(7):1086-1092.

    OpenUrlAbstract/FREE Full Text
20. 1. Wynn RL,
    2. Meiller TF,
    3. Crossley HL

    . Drug information handbook for dentistry. 11th ed. Hudson (OH): LexiComp, Inc.; 2006;79-1184.
21. 1. Calderbank S

    . A vital link: Oral health during cancer therapies (head and neck radiation and/or chemotherapy). Support for People with Oral and Head and Neck Cancer. 2006;16(5):1-3.

    OpenUrl
22. 1. Manne DS

    . Oral mucositis and xerostomia: Challenging oral health conditions. Part I: Oral mucositis. Access. 2006;20(6):34-37.

    OpenUrl
23. 1. Peterson DE,
    2. Bensadoun RJ,
    3. Roila F

    . Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations. Ann Oncol. 2008;19(Suppl. 2):ii122-ii125.

    OpenUrlFREE Full Text
24. 1. McGuire DB,
    2. Correa ME,
    3. Johnson J,
    4. Wienandts P

    . The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer. 2006;14(6):541-547.

    OpenUrlCrossRefPubMedWeb of Science
25. 1. Keefe DM,
    2. Schubert MM,
    3. Elting LS,
    4. et al

    . Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109(5):820-831.

    OpenUrlCrossRefPubMedWeb of Science
26. 1. Harris DJ,
    2. Eilers J,
    3. Harriman A,
    4. Cashavelly BJ,
    5. Maxwell C

    . Putting evidence into practice: Evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs. 2008;12(1):141-152.

    OpenUrlCrossRefPubMedWeb of Science
27. 1. Madrid C,
    2. Abarca M,
    3. Bouferrache K

    . Osteoradionecrosis: An update. Oral Oncol. 2010;46(6):471-474.

    OpenUrlCrossRefPubMed
28. 1. Lyons A,
    2. Ghazali N

    . Osteroradionecrosis of the jaws: Current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008;46(8):653-660.

    OpenUrlCrossRefPubMed
29. 1. Goldwaser BR,
    2. Chuang SK,
    3. Kaban LB,
    4. August M

    . Risk factor assessment for the development of osteoradionecrosis. J Oral Maxillofac Surg. 2007;65(11):2311-2316.

    OpenUrlCrossRefPubMed
30. 1. Ben-David MA,
    2. Diamante M,
    3. Radawski JD,
    4. et al

    . Lack of osteoradionecrosis of the mandible after IMRT for head and neck cancer: Likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68(2):396-402.

    OpenUrlCrossRefPubMed
31. Cancer facts and figures 2008: Estimated new cases and deaths by sex, US, 2008. American Cancer Society [Internet]. 2008 [cited 2009 February 4]. Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf.
32. 1. Scully C,
    2. Bagan J

    . Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4-5):301-308.

    OpenUrlCrossRefPubMedWeb of Science
33. Oral cancer facts. Oral Cancer Foundation [Internet]. [cited 2009 Feb 18]. Available from: http://www.oralcancerfoundation.org/facts/index.htm.
34. 1. Epstein JB,
    2. Gorsky M,
    3. Cabay RJ,
    4. Day T,
    5. Gonsalves W

    . Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: Role of primary care physicians. Can Fam Physician. 2008;54(6):870-875.

    OpenUrlAbstract/FREE Full Text
35. 1. Ward EC,
    2. van As-Brooks CJ

    , editors. Head and neck cancer: Treatment, rehabilitation, and outcomes. San Diego (CA): Plural Publishing; 2006. 13 p.
36. 1. Bayon R,
    2. Wenig BL

    . Carcinoma of the tonsil and oropharynx. Support for People with Oral and Head and Neck Cancer. 2008;18(1):1-3.

    OpenUrl
37. 1. Petti S

    . Lifestyle risk factors for oral cancer. Oral Oncol. 2009;45(4-5):340-350.

    OpenUrlCrossRefPubMedWeb of Science
38. 1. Warnakulasuriya S

    . Risk factors for oral cancer. British Journal of Healthcare Management. 2009;15(11):557-562.

    OpenUrl
39. 1. Warnakulasuriya S

    . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4-5):309-316.

    OpenUrlCrossRefPubMedWeb of Science
40. 1. Shillitoe EJ

    . The role of viruses in squamous cell carcinoma of the oropharyngeal mucosa. Oral Oncol. 2009;45(4-5):351-355.

    OpenUrlCrossRefPubMedWeb of Science
41. 1. Varvares MA,
    2. Manne DS

    . Oral cavity and oropharyngeal cancer: The role of high-risk human papilloma virus. Access. 2008;22(8):44-45.

    OpenUrl
42. 1. Andrews E,
    2. Shores C,
    3. Hayes DN,
    4. et al

    . Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couples. J Infect Dis. 2009;200(6):882-887.

    OpenUrlAbstract/FREE Full Text
43. 1. Gillison ML,
    2. Chaturvedi AK,
    3. Lowy DR

    . HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10):3036-3046.

    OpenUrlCrossRefPubMedWeb of Science
44. 1. Scully C

    . Oral cancer; the evidence for sexual transmission. Br Dent J. 2005;199(4):203-207.

    OpenUrlPubMed
45. 1. Campisi G,
    2. Giovannelli L

    . Controversies surrounding human papilloma virus infection, head and neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol. 2009;1(1):8.

    OpenUrlCrossRefPubMed
46. 1. Chaudhary AK,
    2. Singh M,
    3. Sundaram S,
    4. Mehrotra R

    . Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol. 2009;1(1):22.

    OpenUrlCrossRefPubMed
47. 1. Sikora AG,
    2. Morris LG,
    3. Sturgis EM

    . Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg. 2009;135(4):402-405.

    OpenUrlCrossRefPubMed
48. 1. Haddad R,
    2. Crum C,
    3. Chen Z,
    4. et al

    . HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol. 2008;44(8): 812-815.

    OpenUrlCrossRefPubMedWeb of Science